Title |
Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine
|
---|---|
Published in |
medRxiv
|
DOI | 10.1101/2022.12.17.22283625 |
Authors |
Shrestha, Nabin K., Burke, Patrick C., Nowacki, Amy S., Simon, James F., Hagen, Amanda, Gordon, Steven M. |
Twitter Demographics
The data shown below were collected from the profiles of 46,051 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 6247 | 14% |
Brazil | 1401 | 3% |
United Kingdom | 1106 | 2% |
Japan | 1084 | 2% |
Canada | 1081 | 2% |
France | 712 | 2% |
Australia | 397 | <1% |
Spain | 396 | <1% |
Germany | 368 | <1% |
Other | 3171 | 7% |
Unknown | 30088 | 65% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 44480 | 97% |
Practitioners (doctors, other healthcare professionals) | 667 | 1% |
Scientists | 562 | 1% |
Science communicators (journalists, bloggers, editors) | 290 | <1% |
Unknown | 52 | <1% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18241. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2023.
All research outputs
#43
of 24,479,790 outputs
Outputs from medRxiv
#2
of 45,662 outputs
Altmetric has tracked 24,479,790 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 45,662 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 51.3. This one has done particularly well, scoring higher than 99% of its peers.